NCT01896713View on ClinicalTrials.gov

The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer

NACompletedINTERVENTIONAL

Enrollment

81

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Prostate Cancer

Interventions

OTHER

MS3TMRI

Multispectral 3 Tesla MRI imaging with contrast followed by biopsy

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors

Collaborators (1)

Philips Healthcare

All Listed Sponsors

collaborator

Philips Healthcare

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER

NCT01896713 - The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer | Biotech Hunter | Biotech Hunter